Georgetown University at Washington DC has signed a contract with ISK to run a clinical trial with patients with mtKRAS tumors

On February 17, 2022 The prestigious medical center Georgetown University at Washington DC reported that has sign a contract with ISK to run a clinical trial with patients with mtKRAS pancreas and colon cancers (Press release, Immune System Key, FEB 17, 2022, View Source [SID1234609538]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!